Brought to you by:
WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study completes enrolment
Merit Medical has announced that it has completed enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective, randomized, controlled, multicenter study comparing the Merit WRAPSODY cell-impermeable endoprosthesis (CIE) to percutaneous transluminal angioplasty (PTA)…
SCVS president becomes chair of American Board of Surgery
The American Board of Surgery (ABS) has named Society for Clinical Vascular Surgery (SCVS) President M. Ashraf Mansour, MBBS, as its 2023–24 chair. He was nominated to the ABS by the Association of Program Directors in Vascular Surgery (APDVS) in…
Light-activated drug-coated balloon granted FDA approval for clinical study
Alucent Biomedical has announced that the Food and Drug Administration (FDA) granted an investigational device exemption (IDE) for a U.S. clinical study of AlucentNVS, a light-activated, drug-coated balloon catheter technology. AlucentNVS combines an intravascular device with a photochemical process to…
‘Vascular surgery should be a key member of pulmonary embolism response teams’
“PERT care is the coalition of the willing,” quipped Dennis Gable, MD, a vascular surgeon at Texas Vascular Associates in Plano, Texas. He was referring to team-based care for pulmonary embolism (PE) patients and how, unlike acute stroke intervention and…
SVS urges members to make voices heard on CMS carotid stenting coverage expansion
The SVS has created a template to help members transmit comments to the Centers for Medicare & Medicaid Services (CMS) regarding proposed major adjustments in National Coverage Determination (NCD) 20.7, which covers carotid artery stenting (CAS). The CMS proposal would…
‘FDA’s mission to bring safe and effective vascular surgery devices to market remains steadfast’
The Vascular and Endovascular Devices Team (VEDT) in the Food and Drug Administration (FDA) Office of Cardiovascular Devices appreciates the Vascular Specialist editorial board’s offer to provide an update to the vascular community to enhance regulatory transparency and communication. In…
The top 10 most popular Vascular Specialist stories of July 2023
In the previous month, Vascular Specialist delivered a range of leading commentary from the Society for Vascular Surgery (SVS) in response to the New York Times investigation on inappropriateness in vascular care; the anticipated Food and Drug Administration (FDA) update…
Newest JVS peer-review title appoints editor-in-chief
The Journal of Vascular Surgery (JVS) has announced the appointment of Anahita Dua, MD, as the editor-in-chief of the Journal of Vascular Surgery-Vascular Insights (JVS-VI), the newest title in the JVS stable. Dua, an SVS member, is an associate professor…
Financial viability, appropriate use and patient safety in the operation of outpatient facilities
The number of office-based facilities has been increasing steadily over the past several years—and more vascular surgeons may be considering becoming involved in operating such centers. To help vascular surgeons consider the various details involved, the SVS Subsection on Outpatient…
Comments sought on CMS proposed coverage expansion for carotid stenting
SVS members are encouraged to submit comments—due Aug. 10—to the Centers for Medicare & Medicaid Services (CMS) on its proposed national coverage determination on percutaneous transluminal angioplasty (PTA) of the carotid artery concurrent with stenting. The move would expand coverage…